Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Cordes

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|January 30, 2023
Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal speciesHenrik Cordes, Hermann Rapp
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
NPJ Systems Biology and Applications|March 7, 2018
Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbationHenrik Cordes, Christoph Thiel, Vanessa Baier, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis ChemotherapyHenrik Cordes, Christoph Thiel, Hélène E Aschmann, et al.
Archives of Toxicology|May 11, 2016
Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patientsChristoph Thiel, Henrik Cordes, Isabel Conde, et al.
NPJ Systems Biology and Applications|August 8, 2018
Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situationsChristoph Thiel, Ines Smit, Vanessa Baier, et al.
Frontiers in Physiology|October 16, 2019
A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 PatientsVanessa Baier, Henrik Cordes, Christoph Thiel, et al.
Plos Computational Biology|February 3, 2017
A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant SituationsChristoph Thiel, Henrik Cordes, Lorenzo Fabbri, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 30, 2019
A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer CellsZoe Weydert, Madhu Lal-Nag, Lesley Mathews-Greiner, et al.
Toxicology Letters|May 28, 2018
Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modellingMarcha Verheijen, Yannick Schrooders, Hans Gmuender, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|January 30, 2023
Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal speciesHenrik Cordes, Hermann Rapp
CPT: Pharmacometrics & Systems Pharmacology|April 23, 2026
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time ProfilesFelix Jost, Clemens Giegerich, Christoph Grebner, et al.
NPJ Systems Biology and Applications|March 7, 2018
Integration of genome-scale metabolic networks into whole-body PBPK models shows phenotype-specific cases of drug-induced metabolic perturbationHenrik Cordes, Christoph Thiel, Vanessa Baier, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2016
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis ChemotherapyHenrik Cordes, Christoph Thiel, Hélène E Aschmann, et al.
Archives of Toxicology|May 11, 2016
Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patientsChristoph Thiel, Henrik Cordes, Isabel Conde, et al.
NPJ Systems Biology and Applications|August 8, 2018
Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situationsChristoph Thiel, Ines Smit, Vanessa Baier, et al.
Frontiers in Physiology|October 16, 2019
A Physiology-Based Model of Human Bile Acid Metabolism for Predicting Bile Acid Tissue Levels After Drug Administration in Healthy Subjects and BRIC Type 2 PatientsVanessa Baier, Henrik Cordes, Christoph Thiel, et al.
Plos Computational Biology|February 3, 2017
A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant SituationsChristoph Thiel, Henrik Cordes, Lorenzo Fabbri, et al.
SLAS Discovery : Advancing Life Sciences R & D|October 30, 2019
A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer CellsZoe Weydert, Madhu Lal-Nag, Lesley Mathews-Greiner, et al.
Toxicology Letters|May 28, 2018
Bringing in vitro analysis closer to in vivo: Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modellingMarcha Verheijen, Yannick Schrooders, Hans Gmuender, et al.
Pageof 2